1. Home
  2. FLYE vs KZIA Comparison

FLYE vs KZIA Comparison

Compare FLYE & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLYE
  • KZIA
  • Stock Information
  • Founded
  • FLYE 2018
  • KZIA 1994
  • Country
  • FLYE United States
  • KZIA Australia
  • Employees
  • FLYE N/A
  • KZIA N/A
  • Industry
  • FLYE Aerospace
  • KZIA Biotechnology: Pharmaceutical Preparations
  • Sector
  • FLYE Industrials
  • KZIA Health Care
  • Exchange
  • FLYE Nasdaq
  • KZIA Nasdaq
  • Market Cap
  • FLYE 8.5M
  • KZIA 9.6M
  • IPO Year
  • FLYE 2024
  • KZIA 1999
  • Fundamental
  • Price
  • FLYE $4.00
  • KZIA $7.61
  • Analyst Decision
  • FLYE
  • KZIA Strong Buy
  • Analyst Count
  • FLYE 0
  • KZIA 3
  • Target Price
  • FLYE N/A
  • KZIA $16.00
  • AVG Volume (30 Days)
  • FLYE 55.7K
  • KZIA 1.8M
  • Earning Date
  • FLYE 11-19-2025
  • KZIA 12-26-2025
  • Dividend Yield
  • FLYE N/A
  • KZIA N/A
  • EPS Growth
  • FLYE N/A
  • KZIA N/A
  • EPS
  • FLYE N/A
  • KZIA N/A
  • Revenue
  • FLYE $22,881,935.00
  • KZIA $1,199,108.00
  • Revenue This Year
  • FLYE N/A
  • KZIA N/A
  • Revenue Next Year
  • FLYE N/A
  • KZIA N/A
  • P/E Ratio
  • FLYE N/A
  • KZIA N/A
  • Revenue Growth
  • FLYE N/A
  • KZIA N/A
  • 52 Week Low
  • FLYE $3.85
  • KZIA $2.86
  • 52 Week High
  • FLYE $166.00
  • KZIA $30.05
  • Technical
  • Relative Strength Index (RSI)
  • FLYE 55.70
  • KZIA 53.37
  • Support Level
  • FLYE $5.37
  • KZIA $5.58
  • Resistance Level
  • FLYE $10.37
  • KZIA $8.75
  • Average True Range (ATR)
  • FLYE 0.66
  • KZIA 0.54
  • MACD
  • FLYE -0.14
  • KZIA -0.02
  • Stochastic Oscillator
  • FLYE 34.79
  • KZIA 61.31

About FLYE Fly-E Group Inc. Common Stock

Fly-E Group Inc is an electric vehicle company that is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters and related accessories under the brand Fly E-Bike. It also provides connectivity solutions and value-added services to their customers.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.

Share on Social Networks: